- Home
- ACIU vs GIG Comparison
ACIU vs GIG Comparison
Compare ACIU & GIG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ACIU
- GIG
- Stock Information
- Founded
- ACIU 2003
- GIG 2024
- Country
- ACIU Switzerland
- GIG United States
- Employees
- ACIU N/A
- GIG N/A
- Industry
- ACIU Biotechnology: Pharmaceutical Preparations
- GIG
- Sector
- ACIU Health Care
- GIG
- Exchange
- ACIU Nasdaq
- GIG NYSE
- Market Cap
- ACIU 294.9M
- GIG 334.0M
- IPO Year
- ACIU 2016
- GIG 2024
- Fundamental
- Price
- ACIU $2.65
- GIG $10.05
- Analyst Decision
- ACIU Strong Buy
- GIG
- Analyst Count
- ACIU 2
- GIG 0
- Target Price
- ACIU $12.00
- GIG N/A
- AVG Volume (30 Days)
- ACIU 147.0K
- GIG 10.4K
- Earning Date
- ACIU 03-13-2025
- GIG 01-01-0001
- Dividend Yield
- ACIU N/A
- GIG N/A
- EPS Growth
- ACIU N/A
- GIG N/A
- EPS
- ACIU N/A
- GIG N/A
- Revenue
- ACIU $48,505,404.00
- GIG N/A
- Revenue This Year
- ACIU $86.72
- GIG N/A
- Revenue Next Year
- ACIU $118.28
- GIG N/A
- P/E Ratio
- ACIU N/A
- GIG N/A
- Revenue Growth
- ACIU 4097200.00
- GIG N/A
- 52 Week Low
- ACIU $2.25
- GIG $9.89
- 52 Week High
- ACIU $4.98
- GIG $10.10
- Technical
- Relative Strength Index (RSI)
- ACIU 39.10
- GIG N/A
- Support Level
- ACIU $2.56
- GIG N/A
- Resistance Level
- ACIU $2.83
- GIG N/A
- Average True Range (ATR)
- ACIU 0.16
- GIG 0.00
- MACD
- ACIU -0.00
- GIG 0.00
- Stochastic Oscillator
- ACIU 16.85
- GIG 0.00
About ACIU AC Immune SA
AC Immune SA is a clinical-stage biopharmaceutical company that focuses on neurodegenerative diseases. The company uses its proprietary technology platforms to discover, design, and develop novel proprietary small molecules, antibodies, and vaccines for the prevention, diagnosis, and treatment of neurodegenerative diseases associated with protein misfolding. The Company has one segment. The Company currently focuses most of its resources on discovering and developing therapeutic and diagnostic products targeting misfolded proteins. The company's pipeline consists of ACI-24.060, Crenezumab, ACI-35.030, Semorinemab, ACI-7104.056, and others.
About GIG GIGCAPITAL7 CORP.
GigCapital7 Corp is a Private-to-Public Equity (PPE) company, also known as a blank check company or special purpose acquisition company.